African Journal of Infectious Diseases Research

ISSN 2756-3340

African Journal of Infectious Diseases Research | Vol. 12, No. 5, May 2025 | pp. 331–341

DOI: 10.46882/AJIDR/148780

Article Type: Research Article

Title: Seroprevalence and risk factors of Strongyloides stercoralis infection among immunocompromised patients receiving corticosteroid therapy

Names of Authors: Ezekiel Boateng¹*, Sofia Lindqvist², Carlos Fernandez³

Authors’ Affiliations: ¹Department of Internal Medicine, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana. ²Department of Parasitology, University of Gothenburg, Gothenburg, Sweden. ³Department of Tropical Medicine, University of Antioquia, Medellin, Colombia.

Abstract: Strongyloides stercoralis can persist silently for decades via autoinfection and progress to fatal hyperinfection syndrome during immunosuppressive therapy. We evaluated the seroprevalence and clinical correlates of strongyloidiasis among patients scheduled for systemic corticosteroid treatment. Stool and serum samples from 260 patients were examined using Baermann concentration technique, agar plate culture, and Strongyloides IgG enzyme-linked immunosorbent assay. Seropositivity was detected in 18.5 percent of patients, whereas stool microscopy identified larvae in only 5.4 percent. Peripheral eosinophilia and barefoot agricultural work were significantly associated with infection. Routine serological screening and preemptive ivermectin prophylaxis are recommended prior to immunosuppression.

Keywords: Strongyloides stercoralis, Hyperinfection syndrome, Corticosteroid therapy, Serological screening, Neglected tropical diseases

Citation: Boateng E, Lindqvist S, Fernandez C (2025). Seroprevalence and risk factors of Strongyloides stercoralis infection among immunocompromised patients receiving corticosteroid therapy. African Journal of Infectious Diseases Research, 12(5): 331–341. DOI: 10.46882/AJIDR/148780

Manuscript Timeline: Received: April 07, 2025; Revised: May 09, 2025; Accepted: May 20, 2025; Published: May 30, 2025